Robin Sherrington
Officer (non-Section 16) at XENE
- Sold, on record
- $3.6M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 7, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- XENEXenon Pharmaceuticals Inc.Officer (non-Section 16)
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale XENEPlan not statedMay 28 2021
Sold 6,067 shares at $18.81 ($114k)
Robin Sherrington, EVP, Strategy & Innovation
Sold 15.8% of holdings ($720k position)32,232 shares leftFirst sale on recordFiling
- 2 Form 4 sale XENEUnusualMar 4 +280 days
Sold 21,710 shares at $30.50 ($662k)
Robin Sherrington, EVP, Strategy & Innovation
Sold 55.7% of holdings ($1.2M position)17,232 shares leftFiling
- 3 Form 4 sale XENEUnusualSep 1 +181 days
Sold 65,231 shares at $38.31 ($2.5M)
Robin Sherrington, EVP, Strategy & Innovation
Sold 79.5% of holdings ($3.1M position)16,796 shares leftFiling
- 4 Form 144 notice XENENoticeMar 7 +553 days
Filed to sell 7,137 shares ($330k)
Robin Sherrington, Officer
No 10b5-1 planFiling
- 5 Form 4 sale XENEUnusualMar 7 same day
Sold 7,137 shares at $46.28 ($330k)
Robin Sherrington, EVP, Strategy & Innovation
No 10b5-1 planSold 45.9% of holdings ($719k position)8,398 shares leftFollows a Form 144Filing
- 6 Form 144 notice XENENoticeJun 12 +97 days
Filed to sell 60,000 shares ($2.3M)
Robin Sherrington, Officer (non-Section 16)
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2024 | XENE | Officer (non-Section 16) | Form 144 notice | 60,000 | $2.3M | Notice | SEC | |
| Mar 7, 2024 | XENE | EVP, Strategy & Innovation | Form 4 sale | 7,137 | $330k | 45.9% | Unusual | SEC |
| Mar 7, 2024 | XENE | Officer | Form 144 notice | 7,137 | $330k | Notice | SEC | |
| Sep 1, 2022 | XENE | EVP, Strategy & Innovation | Form 4 sale | 65,231 | $2.5M | 79.5% | Unusual | SEC |
| Mar 4, 2022 | XENE | EVP, Strategy & Innovation | Form 4 sale | 21,710 | $662k | 55.7% | Unusual | SEC |
| May 28, 2021 | XENE | EVP, Strategy & Innovation | Form 4 sale | 6,067 | $114k | 15.8% | Plan not stated | SEC |